ESOR/ESHIMT Course: Introduction to Hybrid Imaging in Oncology
August 30-31, 2018
Thank you to all participants of the course, it was great to see more than 120 imaging specialists interested in hybrid imaging!
14th European Molecular Imaging Meeting
19-22 March 2019
Glasgow, UK – Scottish Event Campus SEC
ESHIMT will be present with a dedicated session at EMIM 2019! More information will follow soon!
- Opening of abstract system: 11 October 2018
- Deadline for abstract submission: 4 December 2018
- Notifications to presenters: mid of January 2019 |
- Deadline early registration: 29 January 2019
1st PET/MRI Symposium
Essen – Tübingen
“PET/MR in oncology – present role and future directions”
3rd & 4th May 2019
The first joint Essen – Tübingen PET/MRI Symposium intends to provide a forum to clinical PET/MR users all around Europe and like to emphasize interactive, moderated dialogues on recent to emerging applications, advanced image processing and image analysis as well as its significance in modern personalized medicine.
We have chosen the parent topic “PET/MRI in oncology – present and future directions” and hope to excite lively discussions in a series of sessions:
- Imaging in oncology: The battle of modalities
- Complex imaging protocols & advanced image analysis
- How do we do it – and what do we do? (Experiences of different PET/MR centers)
- PET/MR in Oncology (prostate, female, pediatric & neuro-oncological imaging)
ESHI Course 2017: Hybrid Imaging in Oncology
December 14-15, 2017 | Vienna, Austria
Enjoy some impressions from the 2017 course in Vienna. More than 150 participants from 42 countries gathered in Vienna to learn more about the indications, limitations and comparative merits of each part in hybrid medical imaging in a wide range of oncologic conditions.
Past Courses 2017
Evolving Hybrid Imaging into Clinical Practice
April 8, 2017, 09.00 – 17.00
ESHI/ESMOFIR Satellite Symposium 2017
Subsequent to the European Molecular Imaging Meeting 2017, the ESHI in collaboration with ESMOFIR organises a Satellite Symposium dedicated “Evolving hybrid imaging into clinical practice” which will take place on Saturday, April 8, 2017.
To register, simply sign in during your EMIM registration. The workshop can be also booked separately!
This course is aimed at radiologists, nuclear medicine physicians and researchers in medical imaging who want to update their knowledge on state-of-the-art hybrid medical imaging. The programme includes basics on hybrid imaging techniques, both on PET-CT and PET-MRI, expanding on the technical background and tracers, but will also give a broad overview on dedicated clinical applications such as hybrid imaging in oncology, cardiovascular imaging or brain imaging. The expert faculty comprises nuclear medicine physicians and radiologists who will provide a series of lectures describing indications and advances in hybrid imaging. Concluding, this course will provide a broad overview of the latest developments in hybrid imaging, as well as a good networking opportunity.
August 31 – September 1, 2017
This course is aimed at last year residents, general radiologists, nuclear medicine physicians and oncologists who want to update their knowledge on new applications and state-of-the-art hybrid medical imaging of cancer. No previous practical experience of the subject is required. The expert faculty comprises nuclear medicine physicians and radiologists who will provide a series of lectures describing optimal imaging pathways for oncological diagnosis, follow-up and response assessment. Lectures will be followed by interactive workshops, presented jointly by faculty specialists.
You can register and find more information on the ESOR Website.
Hybrid Imaging in Oncology
December 14-15, 2017 | Vienna/Austria
- to learn the principles of hybrid medical imaging
- to learn the key clinical questions at different points in the patient’s journey
- to understand the indications, limitations and comparative merits of each part in hybrid medical imaging in a wide range of oncologic conditions, including lymphoma, prostate cancer, gynaecological cancers, as well as brain tumors
- to appreciate the complementary roles of structural and functional/molecular imaging in cancer management
- to understand the importance of standardized protocols for hybrid imaging, and the clinical impact of structured reporting
- to understand how information derived from imaging guides patient selection for treatment and supports individualised treatment planning